loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Sofosbuvir / Velpatasvir reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Sofosbuvir / Velpatasvir

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Epclusa

    02 1Vosevi

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Epclusa

    Sofosbuvir and Velpatasvir

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Discovery on Target
    Not Confirmed

    Gilead

    Sofosbuvir and Velpatasvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,599

    2019 Revenue in Millions : 1,965

    Growth (%) : -19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Epclusa

    Sofosbuvir And Velpatasvir

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Discovery on Target
    Not Confirmed

    Gilead

    Sofosbuvir And Velpatasvir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2016 Revenue in Millions : 1,752

    2015 Revenue in Millions : Not Reported

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Epclusa

    Sofosbuvir and Velpatasvir

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Discovery on Target
    Not Confirmed

    Gilead

    Sofosbuvir and Velpatasvir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2017 Revenue in Millions : 3,510

    2016 Revenue in Millions : 1,752

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Vosevi

    Sofosbuvir 400 mg/Velpatasvir 100 mg/Voxilaprevir 100 mg

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Vosevi

    U.S.A
    arrow
    Discovery on Target
    Not Confirmed

    Gilead

    Sofosbuvir 400 mg/Velpatasvir 100 mg/Voxilaprevir 100 m...

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2017 Revenue in Millions : 293

    2016 Revenue in Millions : New Launch

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Epclusa

    Sofosbuvir And Velpatasvir

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Discovery on Target
    Not Confirmed

    Gilead

    Sofosbuvir And Velpatasvir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2018 Revenue in Millions : 1,966

    2017 Revenue in Millions : 3,510

    Growth (%) : -44%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Epclusa

    Sofosbuvir and Velpatasvir

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Discovery on Target
    Not Confirmed

    Gilead

    Sofosbuvir and Velpatasvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2019 Revenue in Millions : 1,965

    2018 Revenue in Millions : 1,966

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF